How Is Cancer Diagnosed?

 

If your doctor suspects that you have cancer based on your symptoms or the results of a screening test or clinical examination, he or she will order certain diagnostic tests to find out whether you have abnormal cells and, if so, whether they are malignant (cancerous) or non-malignant (non-cancerous). If the tests show that the cells are malignant, you may need more tests to find out more about the cancer cells.

Many types of tests are used to diagnose cancer:

Biopsies -- A biopsy is usually the only way to tell for sure whether you have cancer or not. The doctor cuts out a small piece of tissue (a groupf of similar cells) and sends it to a laboratory to be studied. A pathologist (a doctor who specializes in diagnosing diseases) looks at the tissue under a microscope to see whether it has cancerous cells.

Imaging tests -- These tests or evaluation procedures produce pictures of areas inside the body. They include x-rays, like mammograms, computed tomography (CT or CAT) scans, and magnetic resonance imaging (MRI) scans. Other common imaging tests include ultrasound and positron emission tomography (PET) scans.

Laboratory tests -- A laboratory technician measures substances in the blood or urine that can indicate how advanced the cancer is or other features of your cancer.

Genomics tests -- Polymerase chain reaction (PCR), fluorescent in situ hybridization (FISH), and other genomics tests (tests of genes and their functions) can find mutations (unusual changes) in certain genes that are known to cause cancer.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cancer News
REFILE: Komen charity under microscope for funding, science

February 8, 2012 — NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it spends on grants to scientists working to understand the causes and develop effective new treatments for the disease.

US FDA panel votes against wider use of Amgen drug

February 8, 2012 — WASHINGTON (Reuters) - An advisory panel on Wednesday recommended that U.S. health regulators reject the use of Amgen Inc's drug Xgeva to delay the spread of prostate cancer to the bone, dimming the chance of a wider use for one of the company's key growth drivers.

US consumers want tougher probe of engineered salmon

February 8, 2012 — WASHINGTON (Reuters) - Three U.S. consumer groups petitioned the Food and Drug Administration on Tuesday to subject a new genetically engineered salmon to a more rigorous review process than is now in place before the fish can be approved as safe to eat.

Select news items provided by Reuters Health